Abstract OBJECTIVE: Huntington's disease (HD) is an autosomal dominant disorder characterised by motor, cognitive and psychiatric disturbances. Several studies have demonstrated that hypothalamic dysfunction is part of the phenotypic spectrum. The aim of the study was to evaluate the growth hormone (GH) response to arginine infusion in a cohort of HD patients, to search for an in vivo biomarker of hypothalamic dysfunction. METHODS: The authors investigated 17 HD patients and 17 age-, sex- and BMI-matched healthy controls. Clinical assessment of patients was performed using the Unified Huntington's Disease Rating Scale motor section and total function capacity. Metabolic and endocrine investigations included total, LDL and HDL cholesterol, basal insulin, GH, insulin-like growth factor 1 (IGF-1), SD Score IGF-1 (SDS IGF-1) and the GH response to arginine stimulation. RESULTS: HD patients showed lower plasma IGF-1 and SDS IGF-1 levels and a higher baseline GH in comparison with control subjects. The arginine test induced a normal GH peak in nine patients (53%; Arg+), whereas the response was absent in the remaining eight (47%; Arg-). Arg+ and Arg- also showed two distinct endocrine/metabolic profiles with differences in insulin and lipid metabolism. CONCLUSION: It remains to be clarified if these two subgroups of patients, according to the GH response to arginine, correspond to different disease stages or to different patterns of neurodegeneration.

Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients / Salvatore, Elena; Rinaldi, Carlo; Tucci, T; Di Maio, L; Di Somma, C; Savastano, Silvia; Lombardi, Gaetano; Filla, Alessandro; Colao, Annamaria; DE MICHELE, Giuseppe. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 82:5(2011), pp. 543-548. [10.1136/jnnp.2010.208553]

Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients

SALVATORE, ELENA;RINALDI, CARLO;Di Somma C;SAVASTANO, SILVIA;LOMBARDI, GAETANO;FILLA, ALESSANDRO;COLAO, ANNAMARIA;DE MICHELE, GIUSEPPE
2011

Abstract

Abstract OBJECTIVE: Huntington's disease (HD) is an autosomal dominant disorder characterised by motor, cognitive and psychiatric disturbances. Several studies have demonstrated that hypothalamic dysfunction is part of the phenotypic spectrum. The aim of the study was to evaluate the growth hormone (GH) response to arginine infusion in a cohort of HD patients, to search for an in vivo biomarker of hypothalamic dysfunction. METHODS: The authors investigated 17 HD patients and 17 age-, sex- and BMI-matched healthy controls. Clinical assessment of patients was performed using the Unified Huntington's Disease Rating Scale motor section and total function capacity. Metabolic and endocrine investigations included total, LDL and HDL cholesterol, basal insulin, GH, insulin-like growth factor 1 (IGF-1), SD Score IGF-1 (SDS IGF-1) and the GH response to arginine stimulation. RESULTS: HD patients showed lower plasma IGF-1 and SDS IGF-1 levels and a higher baseline GH in comparison with control subjects. The arginine test induced a normal GH peak in nine patients (53%; Arg+), whereas the response was absent in the remaining eight (47%; Arg-). Arg+ and Arg- also showed two distinct endocrine/metabolic profiles with differences in insulin and lipid metabolism. CONCLUSION: It remains to be clarified if these two subgroups of patients, according to the GH response to arginine, correspond to different disease stages or to different patterns of neurodegeneration.
2011
Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients / Salvatore, Elena; Rinaldi, Carlo; Tucci, T; Di Maio, L; Di Somma, C; Savastano, Silvia; Lombardi, Gaetano; Filla, Alessandro; Colao, Annamaria; DE MICHELE, Giuseppe. - In: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. - ISSN 0022-3050. - 82:5(2011), pp. 543-548. [10.1136/jnnp.2010.208553]
File in questo prodotto:
File Dimensione Formato  
salvatore2010.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 248.93 kB
Formato Adobe PDF
248.93 kB Adobe PDF Visualizza/Apri
salvatore 2010.pdf

solo utenti autorizzati

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 248.93 kB
Formato Adobe PDF
248.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/804627
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact